FR

Fabrice Rosenstiehl

Chief Executive Officer | Senior Advisor | Business Development, Sales, Marketing and Market Access | Medical Technology | Cardiology | DTx | Neuroscience

Paris, Île-de-France

Invests in

Stages:

Locations:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

2022

  • Director TRI Europe

    2022

    Strategic and Business Advisor - Strategic Planning & Execution - Fund Raising

  • Chief Operating Officer

    2022

2019

  • Founder, Senior Advisor

    2019

    Consultant and senior advisor, 1/ Margin expansion through improved customer experience and business model transformation (Life Time Value optimization) 2/ Demand generation (advocacy programmes in the health sector) 3/ Systemic reorganisation Customers range from - Seed & Series A startups to Private Equity - CEO, CMO, COO strategic discussions / advising, and operational discussions with their teams

  • Business Angel

    2018

2022 - 2022

  • Chairman & CEO

    2022 - 2022

2020 - 2021

  • Chief Operating Officer

    2021 - 2021

  • General Manager

    2020 - 2021

2019 - 2019

  • Group Operations Director

    2019 - 2019

2008 - 2018

  • Head of Service Business EMEA

    2017 - 2018

  • Head of Customer and Business Development EMEA

    2008 - 2016

2001 - 2008

  • EMEA Growth Probes Manager

    2007 - 2008

  • Region Services Manager MEA

    2003 - 2007

  • Six Sigma Black Belt

    2001 - 2002

  • Supplier Manager

    2000 - 2001